Treatment of wet age-related macular degeneration by ranibizumab in "real life" in France: treatment behaviours and associated visual outcome

被引：3
|
作者：
Souied, Eric H. [1 ]
Cohen, Salomon-Yves [2 ]
de Pouvourville, Gerard [3 ]
Dupeyron, Gerard [4 ]
Latour, Elisabeth [5 ]
Ponthieux, Anne [5 ]
Weber, Michel [6 ]
机构：
[1] UPEC, Creteil Univ Eye Clin, Interc Hosp Creteil, Creteil, France
[2] Ophthalm Ctr Laser & Med Imagery, Paris, France
[3] ESSEC, Cergy Pontoise, France
[4] Univ Nimes Hosp, Dept Ophthalmol, F-30006 Nimes, France
[5] Novartis Pharma SAS, Rueil Malmaison, France
[6] Hotel Dieu Univ Hosp, Dept Ophthalmol, Nantes, France
来源：
ACTA OPHTHALMOLOGICA | 2015年 / 93卷 / 02期
关键词：
DISEASE;
D O I：
10.1111/aos.12517
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：E179 / E180
页数：2
相关论文
共 50 条
  • [31] Use of Imaging Modalities in Real Life: Impact on Visual Acuity Outcomes of Ranibizumab Treatment for Neovascular Age-Related Macular Degeneration in Germany
    Wachtlin, Joachim
    Spital, Georg
    Schmitz-Valckenberg, Steffen
    Liakopoulos, Sandra
    Voegeler, Jessica
    Mueller, Bettina
    Ziemssen, Focke
    JOURNAL OF OPHTHALMOLOGY, 2020, 2020
  • [32] Ranibizumab for treatment of choroidal neovascularization secondary to age-related macular degeneration
    Bhatnagar, Pawan
    Spaide, Richard F.
    Takahashi, Beatriz S.
    Peragallo, Jason H.
    Freund, K. Bailey
    Klancnik, James M., Jr.
    Cooney, Michael J.
    Slakter, Jason S.
    Sorenson, John A.
    Yannuzzi, Lawrence A.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2007, 27 (07): : 846 - 850
  • [33] Results of Intravitreal Ranibizumab Treatment for Exudative Age-Related Macular Degeneration
    Karaca, Umut
    Durukan, Ali Hakan
    Erdurman, Fazil Cuneyt
    Sobaci, Gungor
    Bayraktar, Mehmet Zeki
    TURK OFTALMOLOJI DERGISI-TURKISH JOURNAL OF OPHTHALMOLOGY, 2012, 42 (01): : 25 - 29
  • [34] PHARMACOECONOMIC EVALUATION OF RANIBIZUMAB IN THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION IN AUSTRIA
    Walter, E.
    Brennig, C.
    Moeremans, K.
    Thomas, V
    VALUE IN HEALTH, 2008, 11 (06) : A617 - A617
  • [35] Pharmacogenetic Studies of Ranibizumab Treatment in Neovascular Age-Related Macular Degeneration
    Den Hollander, A. I.
    Smailhodzic, D.
    Khan, H. A.
    Omar, A.
    Zhang, A. Y.
    Kirchhof, B.
    Chen, J.
    Hoyng, C. B.
    Koenekoop, R. K.
    Fauser, S.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [36] Tachyphylaxis during ranibizumab treatment of exudative age-related macular degeneration
    Sibel Doguizi
    Sengul Ozdek
    Selcen Yuksel
    International Journal of Ophthalmology, 2015, (04) : 846 - 848
  • [37] Tachyphylaxis during treatment of exudative age-related macular degeneration with ranibizumab
    Eghoj, Maria Salling
    Sorensen, Torben Lykke
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2012, 96 (01) : 21 - 23
  • [38] Results of flexible ranibizumab treatment in age-related macular degeneration and search for parameters with impact on outcome
    Gerding, Heinrich
    Loukopoulos, Vlassios
    Riese, Juliane
    Hefner, Lars
    Timmermann, Melanie
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2011, 249 (05) : 653 - 662
  • [39] Predictors of 1-year visual outcome in neovascular age-related macular degeneration following intravitreal ranibizumab treatment
    Bloch, Sara B.
    la Cour, Morten
    Sander, Birgit
    Hansen, Louise K. H.
    Fuchs, Josefine
    Lund-Andersen, Henrik
    Larsen, Michael
    ACTA OPHTHALMOLOGICA, 2013, 91 (01) : 42 - 47
  • [40] Results of flexible ranibizumab treatment in age-related macular degeneration and search for parameters with impact on outcome
    Heinrich Gerding
    Vlassios Loukopoulos
    Juliane Riese
    Lars Hefner
    Melanie Timmermann
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2011, 249 : 653 - 662
12345